(Total Views: 137)
Posted On: 03/16/2021 11:35:50 AM
Post# of 27260

$AVXL News Article - Anavex Life Sciences Reports ANAVEX 2-73 (blarcamesine) featured as a Disease-Modifying Small Molecule in Phase 3 Clinical Trials in a New Publication in Medical Journal titled "Future Avenues for Alzheimer's Disease Detection and Therapy" https://marketwirenews.com/news-releases/anav...16509.html


My Twitter: WhyteStocks